Cell Isolation Market / Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End User (Hospitals, Biotechnology) & Region - Global Forecasts to 2025
Updated on : February 17, 2023
The global cell isolation market in terms of revenue was estimated to be worth $6.9 billion in 2020 and is poised to reach $15.0 billion by 2025, growing at a CAGR of 16.8% from 2020 to 2025. Market growth is driven by the the increasing number of patients suffering from cancer and infectious diseases, increasing government funding for cell-based research, the growing focus on personalized medicine and technological advancements.
To know about the assumptions considered for the study, Request for Free Sample Report
Cell Isolation Market Dynamics
Drivers: Increasing government funding for cell based research
Researchers utilize isolated cells to understand their biology and develop new cell therapies and other cell-based treatments. Various government bodies across the globe have increased their support for the growth of such research activities, owing to its importance. For instance, in January 2016, the Federal Government of Canada granted USD 20 million to the Centre for Commercialization of Regenerative Medicine. This grant will be utilized for establishing a stem-cell therapy development facility in Toronto, Canada. In addition, NIH funding for the development of cell therapies has increased significantly over the last few years. This, in turn, is stimulating the demand for equipment, media, reagents, and accessories used in cell isolation research.
Opportunities: Emerging Markets
Emerging countries, especially in the Asia Pacific region, are expected to become a focal point for growth in the global market. The increasing investments in cell biology research and the growing presence of market players in emerging regions are the major factors responsible for the high growth of this market in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D in order to introduce new drugs in the market. Dr. Reddy’s Laboratories, one of the major players in the Indian pharmaceutical market, spent USD 297 million on R&D in 2017. Such investments are expected to increase the demand for cell isolation products in the country in the coming years. Also, in May 2017, India’s Cabinet Committee on Economic Affairs announced plans to invest ~USD 250 million-half of it to be funded by the World Bank-through 2023 toward industry-academic collaborations to develop vaccines, therapeutics, and medical devices. The program is one of the biggest steps to achieving India’s long-stated goal of growing its biotechnology industry to USD 100 billion by 2025. Due to the increasing R&D activities in the pharmaceutical and biotechnology industries, the adoption of several advanced equipment and methodologies is expected to increase in the country with the aim of increasing productivity.
Restraints: cost of cell- based research
Cell biology involves extensive research on the development of new therapies such as stem cell and gene therapies. The instruments, reagents, and other products associated with this research are required to be of high quality in order to obtain accurate results. Owing to the need to maintain high-quality standards and comply with guidelines set up by regulatory authorities, the cost of research in cell biology is high. In addition, the success rate of cell-based research is very limited, and most cell therapy trials have a low success rate.
Due to budget constraints, various institutes and small-scale companies find it difficult to afford expensive products. This is especially evident in developing countries, where underdeveloped infrastructure facilities and low healthcare expenditure restrict the use of advanced equipment. As a result, the use of automated kits and instruments is limited in these countries. This is one of the major factors restraining the growth of the cell isolation instruments market.
In 2019, consumables segment accounted for the largest share of the cell isolation market, by product
Based on product, the market is segmented into consumables and instruments. The consumables segment accounted for the largest share in the global market in 2019. The increasing investments by companies to develop technologically advanced products as well as the repetitive use of consumables as compared to instruments are the major factors driving the growth of this segment.
In 2019, bone marrow segment accounted for the largest share in the cell isolation market, by cell source
The global market is segmented into bone marrow, adipose tissue and cord blood/ embryonic stem cells. In 2019, the bone marrow segment accounted for the largest share. Over the last decade, the market has witnessed the commercialization of a number of bone marrow-derived stem cell-based products for various therapeutic applications, including cardiovascular disease treatment, tissue regeneration, and musculoskeletal disorders which has supported overall growth in this segment.
In 2019, biotechnology and biopharmaceutical companies segment accounted for the largest share in the cell isolation market, by end user
The global market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The large share of this end-user segment can be attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally.
North America is the largest region for global cell isolation market
Some key players in the cell isolation market (2020- 2025)
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Beckman Coulter Inc.
- Merck KGAA
Cell Isolation Market Report Scope:
|
Report Metric |
Details |
|
Market size available for years |
2016–2025 |
|
Base year considered |
2019 |
|
Forecast period |
2020–2025 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Product, Cell type, Cell Source, Technique, Application, end user, and region |
|
Geographies covered |
North America, Europe, Asia Pacific, RoW |
|
Companies covered |
Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US). |
This report categorizes the cell isolation market into the following segments and subsegments:
By Product
- Consumables
- Instruments
By Cell Type
-
Human Cells
- Differentiated cells
- Stem cells
- Animal cells
By Cell Source
- Bone marrow
- Adipose tissue
- Cord blood/ Embryonic stem cells
By Technique
- Centrifugation- based cell isolation
- Surface marker- based cell isolation
- Filteration- based cell isolation
By Application
- Biomolecule isolation
- Cancer research
- Stem cell research
- Tissue regeneration & regenerative medicine
- In vitro diagnostics
By End User
- Biotechnology and biopharmaceutical companies
- Hospitals and diagnostic laboratories
- Research laboratories and institutes
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific (RoAPAC)
-
Rest of World (RoW)
- Latin America
- Middle East and Africa
Recent Developments
- In May 2019, Thermo Fisher Scientific acquired Brammer Bio with the aim to expand capabilities to support the high growth gene and cell therapy market.
- In October 2018, Merck opened its M Lab Collaboration Center in São Paulo
- In May 2019, Beckman Coulter launched ClearLLab 10C System
Frequently Asked Questions (FAQ):
What are the recent trends affecting the cell isolation market?
Recent trends affecting the cell isolation market are the COVID-19 outbreak, product launches, expansions, partnerships to sustain in the cell isolation market.
What are the cell types used for cell isolation?
The cell isolation market is segmented into human and animal cells based on cell type. In 2019, the human cells segment accounted for the largest share. This can be attributed to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the high and growing incidence of diseases such as cancer.
Who are the key players in the cell isolation market?
The key players in this market are: Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US).
Who are the key end-users of the cell isolation market?
Based on end-users, the cell isolation market is segmented into, biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, research laboratories and institutes and other end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The large share of this end-user segment can be attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally.
Which region is lucrative for the cell isolation market?
Like China, Japan, and India, the emerging economies in the Asia Pacific region will be the lucrative markets for cell isolation products. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 42)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
FIGURE 1 GLOBAL CELL ISOLATION MARKET
1.2.2 COUNTRY COVERAGE
FIGURE 2 GLOBAL MARKET COUNTRY COVERAGE
1.2.3 YEARS CONSIDERED FOR THE STUDY
FIGURE 3 GLOBAL MARKET YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 46)
FIGURE 4 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 6 GLOBAL MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 7 GLOBAL MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 54)
FIGURE 9 GLOBAL MARKET, BY PRODUCT, 2020 VS. 2025 (USD BILLION)
FIGURE 10 GLOBAL MARKET, BY CELL TYPE, 2020 VS. 2025 (USD BILLION)
FIGURE 11 GLOBAL MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
FIGURE 12 GLOBAL MARKET, BY REGION, 2020 VS. 2025 (USD BILLION)
4 PREMIUM INSIGHTS (Page No. - 57)
4.1 CELL ISOLATION: MARKET OVERVIEW
FIGURE 13 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2 NORTH AMERICA: MARKET, BY PRODUCT (2019)
FIGURE 14 CONSUMABLES DOMINATED THE NORTH AMERICAN MARKET IN 2019
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL ISOLATION MARKET
FIGURE 15 COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 59)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Increasing government funding for cell-based research
TABLE 1 NIH FUNDING FOR CELL-BASED RESEARCH, 2014 VS. 2017 (USD MILLION)
5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases
FIGURE 17 INCIDENCE OF CANCER, BY REGION, 2012–2035 (MILLION)
TABLE 2 IMPORTANT STATISTICS ON INFECTIOUS DISEASES
5.2.1.3 Technological advancements
5.2.1.4 Growing focus on personalized medicine
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008–2016
5.2.2 RESTRAINTS
5.2.2.1 Ethical issues related to embryonic stem cell isolation
5.2.2.2 High cost of cell-based research
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.3 COVID-19 IMPACT ON THE CELL ISOLATION/CELL SEPARATION MARKET
6 CELL ISOLATION MARKET, BY PRODUCT (Page No. - 65)
6.1 INTRODUCTION
TABLE 4 GLOBAL MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 5 GLOBAL MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
6.2 CONSUMABLES
TABLE 6 CELL ISOLATION CONSUMBALES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 7 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 8 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 9 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.1 REAGENTS, KITS, MEDIA, AND SERA
6.2.1.1 Owing to the disposable nature of reagents and assay kits, this market is driven by their consistent usage and frequent purchases
TABLE 10 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2016–2019 (USD MILLION)
TABLE 11 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2020–2025 (USD MILLION)
6.2.2 BEADS
6.2.2.1 Growing demand for magnetic beads in T-cell and stem cell isolation is a major factor driving growth in this product segment
TABLE 12 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2016–2019 (USD MILLION)
TABLE 13 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2020–2025 (USD MILLION)
6.2.3 DISPOSABLES
6.2.3.1 Increasing investments in research by governments and companies are a major factor boosting the growth of the cell isolation disposables market
TABLE 14 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2016–2019 (USD MILLION)
TABLE 15 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2020–2025 (USD MILLION)
6.3 INSTRUMENTS
TABLE 16 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 17 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 18 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2016–20219(USD MILLION)
TABLE 19 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.1 CENTRIFUGES
6.3.1.1 Growing use of centrifuges in the pharma-biotech industry and multi-functionality options offered by these instruments are driving the growth of this product segment
TABLE 20 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2016–2019 (USD MILLION)
TABLE 21 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2020–2025 (USD MILLION)
6.3.2 FLOW CYTOMETERS
6.3.2.1 Launch of innovative and cost-effective flow cytometers is likely to drive the growth of the market
TABLE 22 CELL ISOLATION INSTRUMENTS MARKET FOR FLOW CYTOMETERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 23 CELL ISOLATION INSTRUMENTS MARKET FOR FLOW CYTOMETERS, BY REGION, 2020–2025 (USD MILLION)
6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
TABLE 24 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
TABLE 25 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC- ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2020–2025 (USD MILLION)
6.3.4 FILTRATION SYSTEMS
6.3.4.1 Increasing research activities in cell biology to boost the market
TABLE 26 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2016–2019(USD MILLION)
TABLE 27 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2020–2025 (USD MILLION)
7 CELL ISOLATION MARKET, BY CELL TYPE (Page No. - 77)
7.1 INTRODUCTION
TABLE 28 GLOBAL MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 29 GLOBAL MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
7.2 HUMAN CELLS CELL ISOLATION MARKET
TABLE 30 GLOBAL MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 31 GLOBAL MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 32 GLOBAL MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 33 GLOBAL MARKET, BY REGION, 2020–2025 (USD MILLION)
7.2.1 DIFFERENTIATED CELLS
7.2.1.1 Growing investments by market players to develop new and innovative products is expected to support the growth of the differentiated cell isolation market
TABLE 34 HUMAN DIFFERENTIATED CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 35 HUMAN DIFFERENTIATED CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
7.2.2 STEM CELLS
7.2.2.1 Rising government initiatives focused on supporting stem cell research expected to drive market growth
TABLE 36 HUMAN STEM CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 37 HUMAN STEM CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
7.3 ANIMAL CELLS
7.3.1 BIOPHARMACEUTICAL COMPANIES ARE THE MAJOR END USERS OF ISOLATED ANIMAL CELLS
TABLE 38 ANIMAL CELL -SOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 39 ANIMAL CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
8 CELL ISOLATION MARKET, BY CELL SOURCE (Page No. - 84)
8.1 INTRODUCTION
TABLE 40 GLOBAL MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 41 GLOBAL MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
8.2 BONE MARROW
8.2.1 A NUMBER OF BONE MARROW-DERIVED STEM CELLS HAVE BEEN COMMERCIALIZED IN THE LAST DECADE
TABLE 42 BONE MARROW CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 43 BONE MARROW CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
8.3 ADIPOSE TISSUE
8.3.1 ADIPOSE STEM/STROMAL CELLS CAN GENERATE A VARIETY OF OTHER CELL TYPES
TABLE 44 ADIPOSE TISSUE CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 45 ADIPOSE TISSUE CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
8.4 CORD BLOOD/EMBRYONIC STEM CELLS
8.4.1 MARKET GROWTH IS DRIVEN BY THE HIGH THERAPEUTIC POTENCY OF THESE STEM CELLS
TABLE 46 CORD BLOOD/EMBRYONIC STEM CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 47 CORD BLOOD/ EMBRYONIC STEM CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
9 CELL ISOLATION MARKET, BY TECHNIQUE (Page No. - 89)
9.1 INTRODUCTION
TABLE 48 GLOBAL MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 49 GLOBAL MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
9.2 CENTRIFUGATION-BASED CELL ISOLATION
9.2.1 COST-EFFECTIVENESS OF THIS TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS—A MAJOR DRIVER
TABLE 50 CENTRIFUGATION-BASED CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 51 CENTRIFUGATION-BASED CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
9.3 SURFACE MARKER-BASED CELL ISOLATION
9.3.1 WIDE USAGE OF THIS TECHNIQUE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES IS A MAJOR REASON FOR THE GROWTH OF THIS MARKET
TABLE 52 SURFACE MARKER-BASED CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 53 SURFACE MARKER-BASED CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
9.4 FILTRATION-BASED CELL ISOLATION
9.4.1 THE MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET SEGMENT IS THE LOW COST OF THE FILTRATION TECHNIQUE
TABLE 54 FILTRATION-BASED CELL-ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 55 FILTRATION BASED CELL-ISOLATION MARKET, BY REGION, 2020–2025 (USD MILLION)
10 CELL ISOLATION MARKET, BY APPLICATION (Page No. - 95)
10.1 INTRODUCTION
TABLE 56 GLOBAL MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 57 GLOBAL MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
10.2 BIOMOLECULE ISOLATION
10.2.1 BIOMOLECULE ISOLATION DOMINATES THE CELL ISOLATION APPLICATIONS MARKET
TABLE 58 GLOBAL MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2016–2019 (USD MILLION)
TABLE 59 GLOBAL MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2020–2025 (USD MILLION)
10.3 CANCER RESEARCH
10.3.1 HIGH DISEASE INCIDENCE HAS FUELLED THE DEMAND FOR ADVANCED TREATMENT
TABLE 60 GLOBAL MARKET FOR CANCER RESEARCH, BY REGION, 2016–2019 (USD MILLION)
TABLE 61 GLOBAL MARKET FOR CANCER RESEARCH, BY REGION, 2020–2025 (USD MILLION)
10.4 STEM CELL RESEARCH
10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH
TABLE 62 GLOBAL MARKET FOR STEM CELL RESEARCH, BY REGION, 2016–2019 (USD MILLION)
TABLE 63 GLOBAL MARKET FOR STEM CELL RESEARCH, BY REGION, 2020–2025 (USD MILLION)
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
10.5.1 FUNDING FOR REGENERATIVE MEDICINE INITIATIVES HAS RISEN
TABLE 64 GLOBAL MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2016–2019 (USD MILLION)
TABLE 65 GLOBAL MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2020–2025 (USD MILLION)
10.6 IN VITRO DIAGNOSTICS
10.6.1 RISING DISEASE INCIDENCE HAS DRIVEN DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS
TABLE 66 GLOBAL MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2016–2019 (USD MILLION)
TABLE 67 GLOBAL MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2020–2025 (USD MILLION)
11 CELL ISOLATION MARKET, BY END USER (Page No. - 103)
11.1 INTRODUCTION
TABLE 68 GLOBAL MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 69 GLOBAL MARKET, BY END USER, 2020–2025 (USD MILLION)
11.2 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES
11.2.1 FAVORABLE INVESTMENTS HAVE BOOSTED OVERALL PACE OF RESEARCH
TABLE 70 GLOBAL MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2016–2019 (USD MILLION)
TABLE 71 GLOBAL MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2025 (USD MILLION)
11.3 RESEARCH LABORATORIES & INSTITUTES
11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
TABLE 72 GLOBAL MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2016–2019 (USD MILLION)
TABLE 73 GLOBAL MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020–2025 (USD MILLION)
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES
11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES WILL CONTRIBUTE TO MARKET GROWTH
TABLE 74 GLOBAL MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2016–2019 (USD MILLION)
TABLE 75 GLOBAL MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2020–2025 (USD MILLION)
11.5 OTHER END USERS
TABLE 76 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 77 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2025 (USD MILLION)
12 CELL ISOLATION MARKET, BY REGION (Page No. - 110)
12.1 INTRODUCTION
TABLE 78 GLOBAL MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 79 GLOBAL MARKET, BY REGION, 2020–2025 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 18 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
TABLE 80 NORTH AMERICA: MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 81 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 83 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 84 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 85 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 86 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 87 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 88 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 91 NORTH AMERICA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 93 NORTH AMERICA: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 94 NORTH AMERICA: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 95 NORTH AMERICA: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 96 NORTH AMERICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 97 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 98 NORTH AMERICA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 99 NORTH AMERICA: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.2.1 US
12.2.1.1 US to witness the highest growth in the North American cell isolation market due to the increasing government funding on
isolation market due to the increasing government funding on cell-based research
TABLE 100 US: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 101 US: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 102 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 103 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 104 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 105 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 106 US: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 107 US: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 108 US: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 109 US: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 110 US: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 111 US: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 112 US: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 113 US: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 114 US: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 115 US: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 116 US: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 117 US: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada
TABLE 118 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 119 CANADA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 120 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 121 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 122 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 123 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 124 CANADA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 125 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 126 CANADA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 127 CANADA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 128 CANADA: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 129 CANADA: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 130 CANADA: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 131 CANADA: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 132 CANADA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 133 CANADA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 134 CANADA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 135 CANADA: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.3 EUROPE
TABLE 136 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 137 EUROPE: MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 138 EUROPE: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 139 EUROPE: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 140 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 141 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 142 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY INSTRUMENTS, 2016–2019 (USD MILLION)
TABLE 143 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY INSTRUMENTS, 2020–2025 (USD MILLION)
TABLE 144 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 145 EUROPE: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 146 EUROPE: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 147 EUROPE: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 148 EUROPE: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 149 EUROPE: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 150 EUROPE: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 151 EUROPE: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 152 EUROPE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 153 EUROPE: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 154 EUROPE: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 155 EUROPE: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.3.1 GERMANY
12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe
TABLE 156 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019(USD MILLION)
TABLE 157 GERMANY: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 158 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 159 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 160 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 161 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 162 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 163 GERMANY: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 164 GERMANY: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 165 GERMANY: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 166 GERMANY: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 167 GERMANY: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 168 GERMANY: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 169 GERMANY: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 170 GERMANY: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 171 GERMANY: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 172 GERMANY: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 173 GERMANY: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.3.2 FRANCE
12.3.2.1 Increasing prevalence of various chronic and infectious diseases to drive market growth
FIGURE 19 INCIDENCE OF CANCER IN FRANCE
TABLE 174 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 175 FRANCE: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 176 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 177 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 178 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 179 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 180 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 181 FRANCE: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 182 FRANCE: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 183 FRANCE: HUMAN CELLISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 184 FRANCE: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 185 FRANCE: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 186 FRANCE: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 187 FRANCE: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 188 FRANCE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 189 FRANCE: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 190 FRANCE: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 191 FRANCE: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.3.3 UK
12.3.3.1 Government investments in stem cell research to drive the market for cell isolation in the UK
TABLE 192 UK: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 193 UK: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 194 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 195 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 196 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 197 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 198 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 199 UK: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 200 UK: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 201 UK: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 202 UK: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 203 UK: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 204 UK: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 205 UK: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 206 UK: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 207 UK: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 208 UK: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 209 UK: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.3.4 ITALY
12.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell isolation products
TABLE 210 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 211 ITALY: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 212 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 213 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 214 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 215 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 216 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 217 ITALY: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 218 ITALY: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 219 ITALY: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 220 ITALY: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 221 ITALY: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 222 ITALY: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 223 ITALY: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 224 ITALY: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 225 ITALY: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 226 ITALY: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 227 ITALY: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.3.5 SPAIN
12.3.5.1 Increasing funding from private and public organizations to aid market growth
FIGURE 20 INCIDENCE OF CANCER IN SPAIN
TABLE 228 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 229 SPAIN: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 230 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 231 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 232 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 233 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 234 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 235 SPAIN: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 236 SPAIN: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 237 SPAIN: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 238 SPAIN: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 239 SPAIN: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 240 SPAIN: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 241 SPAIN: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 242 SPAIN: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 243 SPAIN: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 244 SPAIN: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 245 SPAIN: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.3.6 REST OF EUROPE (ROE)
TABLE 246 ROE: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 247 ROE: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 248 ROE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 249 ROE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 250 ROE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 251 ROE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 252 ROE: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 253 ROE: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 254 ROE: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 255 ROE: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 256 ROE: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 257 ROE: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 258 ROE: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 259 ROE: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 260 ROE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 261 ROE: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 262 ROE: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 263 ROE: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
TABLE 264 ASIA PACIFIC: MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 265 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 266 ASIA PACIFIC: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 267 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 268 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 269 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 270 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 271 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 272 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 273 ASIA PACIFIC: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 274 ASIA PACIFIC: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 275 ASIA PACIFIC: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 276 ASIA PACIFIC: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 277 ASIA PACIFIC: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 278 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 279 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 280 ASIA PACIFIC: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 281 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 282 ASIA PACIFIC: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 283 ASIA PACIFIC: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.4.1 JAPAN
12.4.1.1 Increasing geriatric population and substantial rise in the prevalence of chronic diseases will drive the market
FIGURE 22 PROJECTED RISE IN CANCER INCIDENCE IN JAPAN
TABLE 284 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 285 JAPAN: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 286 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 287 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 288 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 289 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 290 JAPAN: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 291 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 292 JAPAN: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 293 JAPAN: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 294 JAPAN: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 295 JAPAN: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 296 JAPAN: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 297 JAPAN: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 298 JAPAN: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 299 JAPAN: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 300 JAPAN: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 301 JAPAN: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.4.2 CHINA
12.4.2.1 Cell therapy-based research is growing in China
FIGURE 23 INCIDENCE OF CANCER IN CHINA
TABLE 302 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 303 CHINA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 304 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 305 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 306 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 307 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 308 CHINA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 309 CHINA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 310 CHINA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 311 CHINA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 312 CHINA: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 313 CHINA: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 314 CHINA: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 315 CHINA: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 316 CHINA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 317 CHINA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 318 CHINA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 319 CHINA: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Rising incidence of chronic and infectious disease to drive demand for cell isolation products
FIGURE 24 INCIDENCE OF CANCER IN INDIA
TABLE 320 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 321 INDIA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 322 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 323 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 324 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 325 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 326 INDIA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 327 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 328 INDIA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 329 INDIA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 330 INDIA: GLOBAL MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 331 INDIA: GLOBAL MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 332 INDIA: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 333 INDIA: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 334 INDIA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 335 INDIA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 336 INDIA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 337 INDIA: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.4.4 REST OF ASIA PACIFIC
TABLE 338 ROAPAC: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 339 ROAPAC: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 340 ROAPAC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 341 ROAPAC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 342 ROAPAC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 343 ROAPAC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 344 ROAPAC: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 345 ROAPAC: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 346 ROAPAC: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 347 ROAPAC: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 348 ROAPAC: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 349 ROAPAC: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 350 ROAPAC: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 351 ROAPAC: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 352 ROAPAC: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 353 ROAPAC: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 354 ROAPAC: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 355 ROAPAC: ISOLATION MARKET, BY END USER, 2020–2025 (USD MILLION)
12.5 ROW
TABLE 356 ROW: CELL ISOLATION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 357 ROW: GLOBAL MARKET, BY REGION, 2020–2025 (USD MILLION)
TABLE 358 ROW: GLOBAL MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 359 ROW: GLOBAL MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 360 ROW: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 361 ROW: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 362 ROW: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 363 ROW: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 364 ROW: GLOBAL MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 365 ROW: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 366 ROW: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 367 ROW: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 368 ROW: CELL ISOLATION MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 369 ROW: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 370 ROW: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 371 ROW: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 372 ROW: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 373 ROW: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 374 ROW: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 375 ROW: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.5.1 LATIN AMERICA
12.5.1.1 Rising incidence of chronic and infectious diseases will boost the market during the forecast period
FIGURE 25 NUMBER OF NEW HIV INFECTIONS DIAGNOSED IN LATIN AMERICAN COUNTRIES
TABLE 376 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 377 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 378 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 379 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 380 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 381 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 382 LATIN AMERICA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 383 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 384 LATIN AMERICA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 385 LATIN AMERICA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 386 LATIN AMERICA: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 387 LATIN AMERICA: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 388 LATIN AMERICA: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 389 LATIN AMERICA: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 390 LATIN AMERICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 391 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 392 LATIN AMERICA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 393 LATIN AMERICA: MARKET, BY END USER, 2020–2025 (USD MILLION)
12.5.2 MIDDLE EAST AND AFRICA
12.5.2.1 Increasing availability of funds will support the market in the MEA
TABLE 394 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 395 MIDDLE EAST AND AFRICA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 396 MIDDLE EAST AND AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 397 MIDDLE EAST AND AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 398 MIDDLE EAST AND AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 399 MIDDLE EAST AND AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 400 MIDDLE EAST AND AFRICA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 401 MIDDLE EAST AND AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 402 MIDDLE EAST AND AFRICA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 403 MIDDLE EAST AND AFRICA: HUMAN CELL-ISOLATION MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 404 MIDDLE EAST AND AFRICA: MARKET, BY CELL SOURCE, 2016–2019 (USD MILLION)
TABLE 405 MIDDLE EAST AND AFRICA: MARKET, BY CELL SOURCE, 2020–2025 (USD MILLION)
TABLE 406 MIDDLE EAST AND AFRICA: MARKET, BY TECHNIQUE, 2016–2019 (USD MILLION)
TABLE 407 MIDDLE EAST AND AFRICA: MARKET, BY TECHNIQUE, 2020–2025 (USD MILLION)
TABLE 408 MIDDLE EAST AND AFRICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 409 MIDDLE EAST AND AFRICA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 410 MIDDLE EAST AND AFRICA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 411 MIDDLE EAST AND AFRICA: MARKET, BY END USER, 2020–2025 (USD MILLION)
13 COMPETITIVE LANDSCAPE (Page No. - 224)
13.1 OVERVIEW
FIGURE 26 KEY DEVELOPMENTS IN THE GLOBAL MARKET FROM 2017 TO 2020
13.2 MARKET RANKING ANALYSIS, 2019
FIGURE 27 TOP FIVE COMPANIES IN THE GLOBAL MARKET, 2019
13.3 KEY STRATEGIES
13.3.1 PRODUCT LAUNCHES, 2017–2020
13.3.2 EXPANSIONS, 2017–2020
13.3.3 PARTNERSHIPS, 2017–2020
13.3.4 ACQUISITIONS, 2017–2020
13.4 COMPETITIVE LEADERSHIP MAPPING (2019)
13.4.1 STARS
13.4.2 EMERGING LEADERS
13.4.3 PERVASIVE PLAYERS
13.4.4 PARTICIPANTS
FIGURE 28 CELL ISOLATION MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
14 COMPANY PROFILES (Page No. - 229)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
14.1 THERMO FISHER SCIENTIFIC, INC.
FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
14.2 BECTON, DICKINSON AND COMPANY
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
14.3 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION)
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
14.4 MERCK KGAA
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
14.5 TERUMO BCT (SUBSIDIARY OF TERUMO CORPORATION)
FIGURE 33 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
14.6 GE HEALTHCARE
FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
14.7 BIO-RAD LABORATORIES, INC.
FIGURE 35 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
14.8 CORNING INCORPORATION
FIGURE 36 CORNING INC.: COMPANY SNAPSHOT (2019)
14.9 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMAN-LA ROCHE LTD.)
FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
14.10 ALFA LAVAL
FIGURE 38 ALFA LAVAL: COMPANY SNAPSHOT (2019)
14.11 MILTENYI BIOTEC
14.12 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG
14.13 STEMCELL TECHNOLOGIES, INC.
14.14 AKADEUM LIFE SCIENCES
14.15 BIO-TECHNE
14.16 BIOLEGEND
14.17 BIOLEGEND
15 APPENDIX (Page No. - 256)
15.1 INSIGHTS OF INDUSTRY EXPERTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.4 AVAILABLE CUSTOMIZATIONS
15.5 RELATED REPORTS
15.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the cell isolation market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the cell isolation market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the cell isolation market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global cell isolation market on the basis of product, cell type, cell source, technique, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cell isolation market
- To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW2).
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies3
- To track and analyze competitive developments such as product launches, partnerships, expansions, and acquisitions in the cell isolation market
- To benchmark players within the market using proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
- Cell isolation market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
- Additional five company profiles of players operating in the cell isolation market
Growth opportunities and latent adjacency in Cell Isolation Market